Overview

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Status:
Withdrawn

Trial end date:
2010-05-10

Target enrollment:

Participant gender:

Summary

To monitor the frequency of the development of thrombocytopenia in patients with Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome receiving bivalirudin during Percutaneous Coronary Intervention

Phase:

Phase 4

Details

Lead Sponsor:

The Medicines Company

Treatments:

Bivalirudin
Hirudins